Patents Assigned to Sutter Bay Hospitals
  • Methods and compositions for treating cancer
    Patent number: 11344527
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: May 31, 2022
    Assignee: Sutter Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • MIR-18B for use as a marker of cancer progression and target for therapies to treat cancer
    Patent number: 11142796
    Abstract: The disclosure provides methods for predicting and/or determining whether a subject has cancer based on the level of expression of miR-18b. The disclosure also provides methods for determining whether a cancer in a subject is progressing or regressing based upon the change of expression levels of miR-18b between two time points. The disclosure further provides methods to treat a subject with a cancer by administering a polynucleotide comprising miR-18b and/or an agent that enhances the expression of miR-18b.
    Type: Grant
    Filed: September 19, 2013
    Date of Patent: October 12, 2021
    Assignee: Sutter Bay Hospitals
    Inventors: Mohammed Kashani-Sabet, Altaf A. Dar
  • FALZ for use as a target for therapies to treat cancer
    Patent number: 10526662
    Abstract: The disclosure provides methods for predicting and/or determining whether a subject has cancer based on the level of expression of BPTF. The disclosure also provides methods for determining whether a cancer in a subject is progressing or regressing based upon the change of expression levels of BPTF between two time points. The disclosure further provides methods to treat a subject with a cancer by administering a polynucleotide comprising an inhibitory BPTF nucleic acid and/or an agent that inhibits the expression or activity of BPTF.
    Type: Grant
    Filed: March 19, 2018
    Date of Patent: January 7, 2020
    Assignee: Sutter Bay Hospitals
    Inventors: Mohammed Kashani-Sabet, Altaf A. Dar
  • Resorcinol derivatives
    Patent number: 10202322
    Abstract: The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: February 12, 2019
    Assignee: Sutter Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan
  • Method and kit for dynamic gene expression monitoring
    Patent number: 9360489
    Abstract: This disclosure relates to methods and kits, systems for screening, diagnosing and prognosing a disease, disorder, or physiological state based upon temporal measurements and analysis of gene expression in a subject.
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: June 7, 2016
    Assignee: Sutter Bay Hospitals
    Inventor: Garret L. Yount